Valuation: Ypsomed Holding AG

Capitalization 5.68B 7.13B 6.09B 5.26B 9.76B 612B 10.93B 68.1B 25.85B 285B 26.74B 26.19B 1,047B P/E ratio 2026 *
27.2x
P/E ratio 2027 * 26.2x
Enterprise value 5.9B 7.4B 6.32B 5.46B 10.13B 635B 11.35B 70.71B 26.84B 296B 27.76B 27.19B 1,087B EV / Sales 2026 *
7.81x
EV / Sales 2027 * 7.17x
Free-Float
28.05%
Yield 2026 *
1.01%
Yield 2027 * 1.3%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.36%
1 week-0.95%
Current month-1.07%
1 month+0.60%
3 months+29.21%
6 months+23.12%
Current year+27.63%
More quotes
1 week 411.5
Extreme 411.5
424
1 month 396.5
Extreme 396.5
426.5
Current year 291.5
Extreme 291.5
426.5
1 year 261
Extreme 261
439
3 years 127.4
Extreme 127.4
439
5 years 112.4
Extreme 112.4
439
10 years 100
Extreme 100
439
More quotes
Manager TitleAgeSince
Chief Executive Officer 48 30/06/2014
Director of Finance/CFO 41 31/03/2024
Chief Operating Officer 61 30/09/2015
Director TitleAgeSince
Director/Board Member 48 28/06/2022
Director/Board Member 63 31/12/2017
Director/Board Member 55 31/12/2018
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.36%-0.95%-0.95%+208.71% 7.13B
-0.25%-2.13%+30.59%+22.06% 232B
+1.04%-0.19%+15.28%-1.01% 113B
-1.48%+0.91%+33.23%+109.07% 57.77B
+0.97%-1.71%-22.57%-28.91% 50.05B
+1.09%+3.45%-11.96%+41.19% 39.78B
+0.99%+0.22%-24.52%+3.10% 32.84B
+0.92%-4.67%-9.45%+19.05% 24.69B
-0.30%-1.33%+27.74%-40.26% 22.94B
-0.32%-4.16%+5.80%+11.06% 22.88B
Average +0.41%-1.14%+4.32%+34.41% 60.36B
Weighted average by Cap. +0.54%-0.88%+14.69%+21.35%
See all sector performances

Financials

2026 *2027 *
Net sales 755M 948M 809M 699M 1.3B 81.29B 1.45B 9.05B 3.44B 37.92B 3.55B 3.48B 139B 822M 1.03B 880M 760M 1.41B 88.43B 1.58B 9.85B 3.74B 41.26B 3.87B 3.79B 151B
Net income 205M 257M 220M 190M 352M 22.08B 395M 2.46B 933M 10.3B 965M 945M 37.79B 228M 286M 244M 211M 391M 24.51B 438M 2.73B 1.04B 11.44B 1.07B 1.05B 41.95B
Net Debt 218M 273M 233M 201M 374M 23.43B 419M 2.61B 990M 10.93B 1.02B 1B 40.1B 212M 266M 227M 196M 364M 22.8B 407M 2.54B 964M 10.64B 997M 976M 39.02B
More financial data * Estimated data
Logo Ypsomed Holding AG
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Employees
2,644
More about the company
Date Price Change Volume
09/07/25 418.00 CHF +0.36% 2,550
08/07/25 416.50 CHF -0.36% 10,074
07/07/25 418.00 CHF +0.72% 9,335
04/07/25 415.00 CHF -0.60% 9,749
03/07/25 417.50 CHF +0.24% 15,425

Delayed Quote Swiss Exchange, July 09, 2025 at 09:21 am

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
416.50CHF
Average target price
443.04CHF
Spread / Average Target
+6.37%
Consensus

Quarterly revenue - Rate of surprise